Skip to main content
Facebook
Twitter
LinkedIn
Home
Mobile menu expand icon Menu Close
  • Products
    • Catalog
    • Books
    • Journals
    • LD Connect
  • Services
    • Authors
    • Librarians
    • Reviewers
    • Policies
  • Initiatives
    • Open Science
    • Sustainability
    • Partnerships
    • R&D
    • Labs
  • About
    • Company Story
    • Core Values
    • Memberships
    • News
  • Contact
Doctor and patient with screen showing brain scan

Breadcrumb

  1. Home
  2. News
  3. UTHealth Houston Study: Flu Vaccination Linked to 40% Reduced Risk of Alzheimer’s Disease

UTHealth Houston Study: Flu Vaccination Linked to 40% Reduced Risk of Alzheimer’s Disease

27 June 2022
Neurosciences
Neurosciences
Share this News article

Houston, TX, USA – People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston. Research led by first author Avram S. Bukhbinder, MD, a recent alumnus of McGovern Medical School at UTHealth Houston, and senior author Paul E. Schulz, MD, the Rick McCord Professor in Neurology at McGovern Medical School, compared the risk of Alzheimer’s disease incidence between patients with and without prior flu vaccination in a large nationwide sample of US adults aged 65 and older. The paper detailing the findings is available online in advance of the publication of the Aug. 2 issue of the Journal of Alzheimer’s Disease.

“We found that flu vaccination in older adults reduces the risk of developing Alzheimer’s disease for several years. The strength of this protective effect increased with the number of years that a person received an annual flu vaccine – in other words, the rate of developing Alzheimer’s was lowest among those who consistently received the flu vaccine every year,” said Dr. Bukhbinder, who is still part of Dr. Schulz’s research team while in his first year of residency with the Division of Child Neurology at Massachusetts General Hospital. “Future research should assess whether flu vaccination is also associated with the rate of symptom progression in patients who already have Alzheimer’s dementia.”

The study – which comes two years after UTHealth Houston researchers found a possible link between the flu vaccine and reduced risk of Alzheimer’s disease – analyzed a much larger sample than previous research, including 935,887 flu-vaccinated patients and 935,887 non-vaccinated patients.

During four-year follow-up appointments, about 5.1% of flu-vaccinated patients were found to have developed Alzheimer’s disease. Meanwhile, 8.5% of non-vaccinated patients had developed Alzheimer’s disease during follow-up.

These results underscore the strong protective effect of the flu vaccine against Alzheimer’s disease, according to Dr. Bukhbinder and Dr. Schulz. However, the underlying mechanisms behind this process require further study.

“Since there is evidence that several vaccines may protect from Alzheimer's disease, we are thinking that it isn't a specific effect of the flu vaccine,” said Dr. Schulz, who is also the Umphrey Family Professor in Neurodegenerative Diseases and director of the Neurocognitive Disorders Center at McGovern Medical School. “Instead, we believe that the immune system is complex, and some alterations, such as pneumonia, may activate it in a way that makes Alzheimer's disease worse. But other things that activate the immune system may do so in a different way – one that protects from Alzheimer's disease. Clearly, we have more to learn about how the immune system worsens or improves outcomes in this disease.”

Alzheimer’s disease affects more than 6 million people living in the US, with the number of affected individuals growing due to the nation’s aging population. Past studies have found a decreased risk of dementia associated with prior exposure to various adulthood vaccinations, including those for tetanus, polio, and herpes, in addition to the flu vaccine and others.

Additionally, as more time passes since the introduction of the COVID-19 vaccine and longer follow-up data becomes available, Dr. Bukhbinder said it will be worth investigating whether a similar association exists between COVID-19 vaccination and the risk of Alzheimer’s disease.

Co-authors from McGovern Medical School included Omar Hasan, research coordinator in the Department of Neurology and student at The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences; Kamal N. Phelps, fourth-year medical student; Srivathsan Ramesh, PhD, first-year resident in the Department of Orthopedic Surgery; and alumni Albert Amran, MD, and Ryan Coburn, MD. Co-authors from UTHealth Houston School of Biomedical Informatics included Yaobin Ling, graduate research assistant; Xiaoqian Jiang, PhD, the Christopher Sarofim Family Professor in Biomedical Informatics and Engineering; and Yejin Kim, PhD, assistant professor. Qian Xiao, PhD, MPH, assistant professor in the Department of Epidemiology and Disease Control with UTHealth School of Public Health, also co-authored the study.

Doctor and patient next to a screen with a brain scan

Photo cption: A team of researchers including Paul E. Schulz, MD, found that flu vaccination was associated with a reduced risk for Alzheimer's disease over a four-year period (photo credit: UTHealth Houston)

Written by: Caitie Barkley

###

NOTES FOR EDITORS
Full open access study
: "Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching" by Avram S. Bukhbinder, Yaobin Ling, Omar Hasan, Xiaoqian Jiang, Yejin Kim, Kamal N. Phelps, Rosemarie E. Schmandt, Albert Amran, Ryan Coburn, Srivathsan Ramesh, Qian Xiao, and Paul E. Schulz (DOI: 10.3233/JAD-220361), published online in the Journal of Alzheimer’s Disease in advance of the publication of Volume 88, Issue 3. The open access article is available at: content.iospress.com/articles/journal-of-alzheimers-disease/jad220361.

Contact
Further information can be obtained from the media office at UTHealth Houston (+1 713 500 3030).

About the Journal of Alzheimer's Disease
Now in its 24th year of publication, the Journal of Alzheimer’s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease, and clinical trial outcomes. JAD has a Journal Impact Factor of 4.160 according to Journal Citation Reports (Clarivate, 2022). j-alz.com

Related news items

Graphical illustration of study finding exposure to WTC dust exacerbates cognitive impairment in mouse model of Alzheimer’s
17 January 2023

Exposure to World Trade Center Dust Exacerbates Cognitive Impairment in an Animal Model of Alzheimer’s

New York, NY, USA  – Mice exposed to World Trade Center dust exhibit a significant impairment in spatial recognition and short- and long-term memory, as well as...

Read more
green JAD cover on a pale green background with blue dots behind the cover
22 December 2022

Smoking increases chances of mid-life memory loss, confusion

Columbus, OH, USA – Middle-aged smokers are far more likely to report having memory loss and confusion than nonsmokers, and the likelihood of cognitive decline...

Read more
JAD_4 elderly women outside looking at map
22 December 2022

Why a healthy lifestyle is not enough to prevent dementia

Leipzig, Germany – Dementia is on the rise in Germany. In the absence of treatment options, the focus is shifting to preventing dementia. In particular, a...

Read more

Subscribe To Our Quarterly Newsletter

Home

Accelerate Research. Increase Impact.

© IOS Press

View News View Catalog

Legal

  • Disclaimer
  • Privacy Policy

Menu

  • About
  • News
  • Catalog
  • Initiatives
  • Products
  • Services

Quick Links

  • Publish With Us
  • Sustainability & SDGs
  • Open Library
  • Policies
  • Sitemap
  • FAQs

Contact

IOS Press

Nieuwe Hemweg 6B

1013 BG Amsterdam

the Netherlands

iospress.com

Contact Us
Facebook
Twitter
LinkedIn
© IOS Press 2023 - Terms of use - Privacy policy
Powered by Dropsolid